Healthcare provider profile · identity verified

Stanton L Danielson, MD

Family Practice · ALTOONA, IA · NPI 1629038195

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	819	157
Atorvastatin Calcium	Atorvastatin Calcium	654	152
Omeprazole	Omeprazole	544	120
Lisinopril	Lisinopril	518	117
Amlodipine Besylate	Amlodipine Besylate	505	126
Simvastatin	Simvastatin	409	82
Metoprolol Succinate	Metoprolol Succinate	344	82
Losartan Potassium	Losartan Potassium	327	86
Furosemide	Furosemide	309	73
Potassium Chloride	Potassium Chloride	288	67
Pantoprazole Sodium	Pantoprazole Sodium	278	59
Tamsulosin Hcl	Tamsulosin Hcl	235	51
Jardiance	Empagliflozin	227	37
Pravastatin Sodium	Pravastatin Sodium	222	53
Escitalopram Oxalate	Escitalopram Oxalate	212	55
Warfarin Sodium	Warfarin Sodium	210	30
Duloxetine Hcl	Duloxetine Hcl	198	39
Metformin Hcl Er	Metformin Hcl	186	48
Rosuvastatin Calcium	Rosuvastatin Calcium	182	51
Gabapentin	Gabapentin	179	47
Metformin Hcl	Metformin Hcl	165	42
Ozempic	Semaglutide	151	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	137	43
Allopurinol	Allopurinol	136	34
Hydrochlorothiazide	Hydrochlorothiazide	135	42
Mirtazapine	Mirtazapine	128	21
Eliquis	Apixaban	123	29
Citalopram Hbr	Citalopram Hydrobromide	110	18
Trazodone Hcl	Trazodone Hcl	102	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	96	23
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	96	24
Sertraline Hcl	Sertraline Hcl	92	22
Famotidine	Famotidine	90	19
Donepezil Hcl	Donepezil Hcl	89	13
Metoprolol Tartrate	Metoprolol Tartrate	89	25
Ezetimibe	Ezetimibe	88	31
Glimepiride	Glimepiride	88	25
Venlafaxine Hcl Er	Venlafaxine Hcl	84	16
Lorazepam	Lorazepam	81	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	79	18
Cephalexin	Cephalexin	78	59
Xarelto	Rivaroxaban	78	15
Atenolol	Atenolol	77	13
Esomeprazole Magnesium	Esomeprazole Magnesium	74	suppressed
Meloxicam	Meloxicam	73	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	71	22
Tramadol Hcl	Tramadol Hcl	70	23
Memantine Hcl	Memantine Hcl	67	suppressed
Tizanidine Hcl	Tizanidine Hcl	64	11
Pregabalin	Pregabalin	63	12
Albuterol Sulfate Hfa	Albuterol Sulfate	60	27
Clonazepam	Clonazepam	60	11
Hydralazine Hcl	Hydralazine Hcl	56	suppressed
Levetiracetam	Levetiracetam	56	suppressed
Fluticasone Propionate	Fluticasone Propionate	55	21
Montelukast Sodium	Montelukast Sodium	54	15
Triamcinolone Acetonide	Triamcinolone Acetonide	54	30
Alprazolam	Alprazolam	53	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	53	13
Carbamazepine Er	Carbamazepine	52	suppressed
Terazosin Hcl	Terazosin Hcl	52	suppressed
Ropinirole Hcl	Ropinirole Hcl	51	12
Alendronate Sodium	Alendronate Sodium	50	11
Finasteride	Finasteride	49	12
Lovastatin	Lovastatin	49	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	48	11
Phenobarbital	Phenobarbital	48	suppressed
Clonidine Hcl	Clonidine Hcl	47	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	46	suppressed
Buspirone Hcl	Buspirone Hcl	45	suppressed
Clopidogrel	Clopidogrel Bisulfate	44	suppressed
Carvedilol	Carvedilol	43	13
Ipratropium Bromide	Ipratropium Bromide	43	15
Benazepril Hcl	Benazepril Hcl	41	suppressed
Carbamazepine	Carbamazepine	38	suppressed
Humalog Kwikpen U-100	Insulin Lispro	38	suppressed
Propranolol Hcl	Propranolol Hcl	38	suppressed
Risperidone	Risperidone	37	suppressed
Livalo	Pitavastatin Calcium	36	suppressed
Methylprednisolone	Methylprednisolone	36	31
Phenytoin	Phenytoin	35	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	34	suppressed
Baclofen	Baclofen	33	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Fenofibrate	Fenofibrate,micronized	33	suppressed
Nitroglycerin	Nitroglycerin	33	29
Amitriptyline Hcl	Amitriptyline Hcl	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	32	28
Prednisone	Prednisone	32	15
Spironolactone	Spironolactone	32	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	31	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	suppressed
Oxycodone Hcl	Oxycodone Hcl	31	suppressed
Tresiba Flextouch U-100	Insulin Degludec	31	11
Fenofibrate	Fenofibrate	30	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	30	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Enalapril Maleate	Enalapril Maleate	29	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	29	15
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Bupropion Hcl	Bupropion Hcl	27	12
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	25	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Bumetanide	Bumetanide	24	suppressed
Glipizide	Glipizide	23	suppressed
Azithromycin	Azithromycin	22	21
Benztropine Mesylate	Benztropine Mesylate	22	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	20	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Dulera	Mometasone/Formoterol	18	suppressed
Midodrine Hcl	Midodrine Hcl	18	suppressed
Naproxen	Naproxen	18	suppressed
Novofine 32	Pen Needle, Diabetic	18	suppressed
Cholestyramine	Cholestyramine (With Sugar)	17	suppressed
Metolazone	Metolazone	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Dexlansoprazole Dr	Dexlansoprazole	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Verapamil Er	Verapamil Hcl	16	suppressed
Desmopressin Acetate	Desmopressin Acetate	15	suppressed
Divalproex Sodium Er	Divalproex Sodium	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	13
Irbesartan	Irbesartan	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Lurasidone Hcl	Lurasidone Hcl	15	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Lactulose	Lactulose	14	suppressed
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Praluent Pen	Alirocumab	14	suppressed
Galantamine Hbr	Galantamine Hbr	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	12
Trulicity	Dulaglutide	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Topiramate	Topiramate	12	suppressed
Trandolapril	Trandolapril	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error